Prothena Corp Public (PRTA) Cash from Investing Activities Growth (3y) (2015 - 2025)
Prothena Corp Public (PRTA) Cash from Investing Activities Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Prothena Corp Public |
479.08 Mn |
149.61 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
57.47% |
| Jun 30, 2025 |
18.86% |
| Mar 31, 2025 |
-24.05% |
| Dec 31, 2024 |
48.73% |
| Sep 30, 2024 |
64.89% |
| Mar 31, 2024 |
-28.98% |
| Dec 31, 2023 |
-209.50% |
| Sep 30, 2023 |
-79.05% |
| Jun 30, 2023 |
-155.92% |
| Mar 31, 2023 |
-29.70% |
| Dec 31, 2022 |
-12.52% |
| Sep 30, 2022 |
19.48% |
| Jun 30, 2022 |
-32.64% |
| Mar 31, 2022 |
43.66% |
| Dec 31, 2021 |
37.35% |
| Sep 30, 2021 |
-11.02% |
| Mar 31, 2021 |
35.75% |
| Dec 31, 2020 |
48.62% |
| Sep 30, 2020 |
47.69% |
| Jun 30, 2020 |
39.53% |
